Camp4 Therapeutics (CAMP) Other Non-Current Assets (2023 - 2026)
Camp4 Therapeutics recorded quarterly Other Non-Current Assets of $1.6 million in Q1 2026, up 1827.71% quarter-over-quarter from $83000.0 in Q4 2025, and down 1.48% year-over-year from $1.6 million in Q1 2025.
Camp4 Therapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 1.48% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 1.48% YoY), while the FY2025 annual figure was $83000.0, down 80.56% from the prior year.
- Other Non-Current Assets came in at $1.6 million for Q1 2026 at Camp4 Therapeutics, up from $83000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.6 million in Q3 2023 to a low of $83000.0 in Q4 2025.
- A 4-year average of $1.3 million and a median of $1.6 million in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets changed 0.0% in 2024 and tumbled 80.56% in 2025, its largest moves.
- Camp4 Therapeutics' Other Non-Current Assets stood at $1.6 million in 2023, then sank by 73.71% to $427000.0 in 2024, then sank by 80.56% to $83000.0 in 2025, then surged by 1827.71% to $1.6 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.6 million, $83000.0, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 83,000.00 |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 427,000.00 |
| Sep 30, 2024 | 1.62 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 1.62 Mn |